Cosmos Health (COSM) Reports Q3 Results

Go back to Cosmos Health (COSM) Reports Q3 Results

Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M QoQ

November 15, 2024 10:21 AM EST

Stable revenue and gross profit despite cost-cutting initiatives, indicating the strength of underlying segments and brands.

Solid liquidity position, with cash and cash equivalents exceeding $3.3 million.

Hard assets, mainly comprised of debt-free properties, valued at over $12 million; exceeding total debt and providing financing flexibility.

Liquid inventory position and accounts receivable that are collected at an accelerated pace provide additional flexibility.

Record-breaking results at CosmoFarm and in Amazon UK sales.

Various... More